Analysis of the cases of Hantavirus in the United State to avoid the next outbreak
DOI:
https://doi.org/10.54097/hset.v36i.5728Keywords:
Hantavirus, United State, Next break, Hemorrhagic Fever with Renal Syndrome (HFRS), Hantavirus Pulmonary Syndrome (HPS).Abstract
Hantaviruses have always existed in today’s society, and people in many countries have been attacked by rodents, or unknowingly in contact with rodent fluids, leading to a silent increase in the number of hantavirus cases. Compared to the current COVID-19 epidemic, the hantavirus is not well known to the world, but in fact, not only in the United States but in China, HFPS cases account for more than half of the confirmed cases globally. Both HPS and HFPS can lead to severe clinical features such as hypotensive shock, renal failure, and other symptoms. At present, there is no specific medicine, and the vaccine technology is not mature. Vaccines are still in development and have not yet reached the ideal state. So, this essay is to summarize the past surveillance and control of the hantavirus in the United States to reduce the possibility of a resurgence of the virus. By explaining the cases of hantavirus in the United States and the work, race, gender, and many different aspects of the patients, the current treatment direction and methods of hantavirus are explained. On the whole, people should pay more attention to epidemic monitoring, strengthen customs management, strengthen people's awareness of the hantavirus, and strengthen education in high-risk areas, to be more able to control the outbreak of the epidemic.
Downloads
References
St Maurice A, et al. Exposure Characteristics of Hantavirus Pulmonary Syndrome Patients, United States, 1993-2015. Emerg Infect Dis. 2017 May;23(5):733-739.
Jonsson, Colleen B et al. “A global perspective on hantavirus ecology, epidemiology, and disease.” Clinical microbiology reviews vol. 23,2 (2010): 412-41.
Straková, Petra et al. “Novel hantavirus identified in European bat species Nyctalus noctula.” Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases vol. 48 (2017): 127-130.
Forbes, Kristian M et al. “Hantavirus maintenance and transmission in reservoir host populations.” Current opinion in virology vol. 28 (2018): 1-6.
Jonsson, C. B., et al. (2010). A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease. https://journals.asm.org
CDC, C. D. C. (2019). Transmission. CDC. Retrieved September 9, 2022, from https://www.cdc.gov/hantavirus/hps/transmission.html
CDC, C. D. C. (2022). Hantavirus Infection in the United States. Reported Cases of Hantavirus Disease. Retrieved September 20, 2022, from https://www.cdc.gov/hantavirus/surveillance/index.html
WHO, W. H. O. (2019). Hantavirus Pulmonary Syndrome - Argentina. WHO. Retrieved September 20, 2022, from https://www.who.int
Hu Haifeng, et al. Advances in antiviral therapy and vaccine development for hemorrhagic fever with renal syndrome [J]. Infectious Disease Information, 2020,33(03):198-201.
Slough, Megan M et al. “Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.” mBio vol. 10,1 e02372-18. 8 Jan. 2019,
Jiang, Dong-Bo et al. “Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy.” Antiviral research vol. 150 (2018): 174-182.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
